Clinical Trials in Dallas

Showing 6741-6760 of 17,468 trials

A Relative Bioavailability Study of Peresolimab (LY3462817) Formulations in Healthy Participants

NCT05959109

The main purpose of this study is to look at the amount of the study drug, peresolimab, that gets into the blood stream and how long it takes the body to get rid of it when given under the skin using test formulations versus reference formulation in healthy participants. The study will also evaluate the safety and tolerability of peresolimab and information about any side effects experienced will be collected. For each participant, the total duration of the study will be approximately up to 17 weeks, including screening.

Healthy

Eli Lilly and Company57 participantsStarted Jul 2023

Dallas, Texas, United States

COMPLETED< 1 mile

A Multicenter Retrospective Review of Management Strategies in Small Bowel Obstruction

NCT06223620

The objective of the study is to review performance of water soluble contrast study in patients admitted with Small Bowel Obstruction(SBO), will improve quality and safety, and decrease length of stay and morbidity.

SBO - Small Bowel Obstruction

Methodist Health System504 participantsStarted Jul 2018

Dallas, Texas, United States

COMPLETEDNA< 1 mile

A Study to Assess Long-Term Safety of the CyPass Micro-Stent in Patients Completing the COMPASS Trial

NCT02700984

The purpose of this study is to evaluate the long-term safety of the CyPass Micro-Stent in subjects who completed Study Protocol TMI-09-01, COMPASS Trial.

Primary Open Angle Glaucoma (POAG)

Alcon Research282 participantsStarted Mar 2016

Glendale, Arizona, United States • Fayetteville, Arkansas, United States • La Jolla, California, United States +19 more locations

A Relative Bioavailability Study of Peresolimab (LY3462817) Formulations in Healthy Participants

A Multicenter Retrospective Review of Management Strategies in Small Bowel Obstruction

A Study to Assess Long-Term Safety of the CyPass Micro-Stent in Patients Completing the COMPASS Trial

Find Trials by Condition in Dallas

Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee

Study of FX006 vs Normal Saline in Patients With Osteoarthritis of the Knee

A Study for Oral SY-2101 for Participants With Acute Promyelocytic Leukemia

V160 2-Dose and 3-Dose Regimens in Healthy Cytomegalovirus (CMV) Seronegative Females (V160-002)

Study to Evaluate the Efficacy and Safety of FX006 in Patients With Glenohumeral Osteoarthritis or Shoulder Adhesive Capsulitis

Growth and Tolerance of a Partially Hydrolyzed Infant Formula

A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody in Solid Tumors

Study Evaluating the Treatment of OTX-TKI for Subjects With Neovascular Age-related Macular Degeneration

A Study of CART-TnMUC1 in Patients With TnMUC1-Positive Advanced Cancers

RoBotic TCD Ultrasound BubbLe Study Compared to Transthoracic Echocardiography for Detection of Right to Left Shunt

Ankle Joint Replacement Outcomes Study

Study to Evaluate the Efficacy and Safety of FX006 in Patients With Hip Osteoarthritis

Study to Evaluate the Iovera° Device for Temporary Relief From Knee Pain

Study to Evaluate the Effect of FX006 on Synovial Inflammation in Patients With OA of the Knee

Study to Evaluate a Procedure for Intra-articular Injection of FX006 in Patients With Osteoarthritis of the Hip

A Study of Mirikizumab in Participants With Plaque Psoriasis

Study to Compare Exposure of TA Following Administration of FX006 or TAcs in Patients With OA of the Shoulder or Hip